Form 8-K - Current report:
SEC Accession No. 0001193125-25-184619
Filing Date
2025-08-21
Accepted
2025-08-21 07:00:38
Documents
18
Period of Report
2025-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d27011d8k.htm   iXBRL 8-K 58667
2 EX-99.1 d27011dex991.htm EX-99.1 29076
7 GRAPHIC g27011g0821034745545.jpg GRAPHIC 5594
8 GRAPHIC g27011g0821034745760.jpg GRAPHIC 844
9 GRAPHIC g27011g0821034745974.jpg GRAPHIC 854
10 GRAPHIC g27011g0821034746192.jpg GRAPHIC 964
  Complete submission text file 0001193125-25-184619.txt   273429

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250816.xsd EX-101.SCH 4438
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250816_def.xml EX-101.DEF 13841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250816_lab.xml EX-101.LAB 23110
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250816_pre.xml EX-101.PRE 14810
21 EXTRACTED XBRL INSTANCE DOCUMENT d27011d8k_htm.xml XML 6100
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)